Wuhan YZY Biopharma Co., Ltd. Class H (HK:2496) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Wuhan YZY Biopharma Co., Ltd. has announced its first extraordinary general meeting (EGM) of 2024, to be held on October 22, where shareholders will vote on key resolutions including the removal and appointment of non-executive directors, and amendments to the Articles of Association. The meeting will take place in Wuhan, Hubei Province, and resolutions will be published on the company and Stock Exchange websites following the EGM. Shareholders are entitled to appoint proxies to vote on their behalf and must register transfers of shares by October 16 to be eligible to vote.
For further insights into HK:2496 stock, check out TipRanks’ Stock Analysis page.